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A B S T R A C T
The development of protein corona around nanoparticles upon administration to the human body is responsible
in a large part for their biodistribution, cell-internalization and toxicity or biocompatibility. We studied the
inﬂuence of the chemical composition of polyelectrolyte shells (citric acid (CA) and poly(acrylic-co-maleic acid)
(PAM)) of core-shell magnetite nanoparticles (MNPs) on the evolution of protein corona in human plasma (HP).
The aggregation state and zeta potential of the particles were measured in the range of HP concentration
between 1 and 80 (v/v)% 3 min and 20 h after dispersing the particles in HP diluted with Tris buﬀered saline.
Naked MNPs aggregated in HP solution, but the carboxylated MNPs became stabilized colloidally at higher
plasma concentrations. Signiﬁcant diﬀerences were observed at low plasma concentration. CA@MNPs
aggregated instantly while the hydrodynamic diameter of PAM@MNP increased only slightly at 1–3 v/v %
HP concentrations. The observed diﬀerences in protein corona formation can be explained by the diﬀerences in
the steric eﬀects of the polycarboxylate shells. It is interesting that relatively small but systematic changes in
zeta potential alter the aggregation state signiﬁcantly.
1. Introduction
Superparamagnetic iron oxide (SPIO) nanoparticles (designated
here as MNP – short for magnetite nanoparticles) are eﬀective agents
for contrast enhancement in magnetic resonance imaging, magnetic
drug delivery and release, and magnetic hyperthermia treatments [1–
3]. MNPs with hydrodynamic diameters of 80–150 nm are cleared
from the organism via the reticuloendothelial system (RES), while
smaller particles can remain in the blood pool circulation for longer
[4,5] providing the possibility for biomedical applications.
Proteins adsorb instantaneously on nanoparticle surfaces [6–8],
which determines their fate in biological media by way of creating a
bio-nano interface sensed by cells and other structures of the human
body. A comprehensive review of our present knowledge on the
interaction of proteins with nanoparticles and protein corona forma-
tion mechanisms in biorelevant media is given in the work of Rahman
et al. [9]. The properties of protein coronas diﬀer signiﬁcantly
depending on the surface chemistry of the nanoparticles and in turn,
the surface chemistry has a deciding role not only in the formation of
protein corona but also in the cellular uptake of the particles [6,10–12].
The main observations are that corona formation is largely aﬀected by
surface hydration or hydrophobicity, surface charge and the thickness
of the shell coating the nanoparticles. In some cases, even the absence
of protein corona was detected on core-shell nanoparticles [10].
Systematic studies have been performed in order to test a wide range
of polyelectrolytes (e.g., polyacrylic acid [10], polyethylene imine [13],
polyethylene glycol [14,15], or natural polysaccharides [16]) to synthe-
size so called core-shell nanoparticles. Citric acid is also used fre-
quently as surface modiﬁer [e.g. 17, one of the most recent], albeit
many studies reveal contraindications for in vivo application of citrate
stabilized particles [18–20]. Modiﬁcation of the chemistry of bio/nano
interfaces allows for designing appropriate protein corona composition
for speciﬁc biomedical aims. Proteomics studies are used eﬃciently for
testing protein composition of coronas formed on various nanoparti-
cles and the dynamics of corona formation [7,14,15]. Despite the vast
amount of experimental data, further quantitative studies are needed to
improve our insight into the mechanism and biomedical consequences
of protein corona formation [21]. The eﬀect of protein corona forma-
tion on colloidal stability of nanoparticles seems to be a neglected area.
Our aim was to study the eﬀect of the composition of polycarbox-
ylate coatings on the colloidal stability of magnetite nanoparticles
(MNP) of ~8 nm in diameter [22,23] in buﬀered human plasma (HP)
solutions at pH~7.4in comparison to that of naked MNPs. The MNPs
are coated by citrate (CA@MNP) and poly(arcylic-co-maleic acid)
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(PAM@MNP) according to previously published protocols [23,24].
Colloidal stability was tested in water at bio-relevant pH (~6.5) and
the critical coagulation concentration (CCC) in NaCl solutions were
found to be 1, 70 and 500 mM for MNP, CA@MNP and PAM@MNP,
respectively [23,24]. Herein, we studied how much the in vitro
formation of protein corona aﬀects the aggregation propensity of these
formulations. As biomedical application of citrate coated MNPs is
frequently found in literature [e.g., 25], our aim was to test whether
these particles can acquire suﬃcient colloidal stability in biological
media due to protein corona formation. Human plasma was preferred
versus human serum in our experiments (because the protein composi-
tion of the former is more similar to that of blood [26]) as well as versus
whole blood (because the presence of micron-sized cells and platelets
in whole blood would make DLS and zeta potential measurements
impossible). The presence of coatings on MNP was veriﬁed with XPS
measurements. The colloidal stability and zeta potential of the particles
in HP solution media were studied in dynamic light scattering and
electrokinetic measurements. The kinetics of protein corona formation
and the eﬀect of HP concentration on colloidal stability were also
studied.
2. Materials and methods
Magnetite nanoparticles were synthesized using the method of co-
precipitation of Fe(II) and Fe(III) salts as described in detail in [23].
The polyelectrolyte shells were formed around the MNP cores in the
process of physico-chemical adsorption of citric acid (CA) monomers
[24] and commercial PAM (Sigma-Aldrich) [24] polyelectrolyte. HCl,
NaOH and NaCl (Molar, Hungary) were used to adjust the pH and ionic
strength in the MNP, CA@MNP and PAM@MNP stock dispersions to
pH ~6.5 and I=10 mM to ensure long term stability. The nanoparticle
dispersions were then mixed with human plasma (HP) and Tris
buﬀered saline (pH~7.4, I=0.154 M, Sigma-Aldrich) was used to adjust
the volume to ﬁnal HP concentrations. Ultrapure water (UP water, 18
MΩ) from a HumanCorp Zeneer water puriﬁcation system was used in
the experiments.
The chemical composition (atomic concentrations), as well as the
chemical state of the atoms at the surface of CA- and PAM- coated
MNPs (CA@MNP and PAM@MNP), were determined by X-ray
Photoelectron Spectroscopy (XPS). The spectra were recorded using a
spectrometer SPECS equipped with a dual-anode X-ray source Al/Mg,
a PHOIBOS 150 2D CCD hemispherical energy analyzer and a multi-
channeltron detector with vacuum maintained at 1×10−9 Torr. The
AlKα X-ray source (1486.6 eV) operated at 200 W was used for XPS
investigations. The XPS survey spectra were recorded at 30 eV pass
energy and 0.5 eV/step. The high-resolution spectra for individual
elements were recorded by accumulating 10 scans at 30 eV pass energy
and 0.1 eV/step. The powder suspensions were dried on an indium foil
to allow the XPS measurements. The surface of the particles was
cleaned by argon ion bombardment (300 V). Data analysis and curve
ﬁtting was performed using CasaXPS software with a Gaussian-
Lorentzian product function and a non-linear Shirley background
subtraction.
The blood of six healthy Donors (age of 30–64, ﬁve females and one
male) was collected in the Institute of Laboratory Medicine of the
University of Szeged according to the routine blood drawing practice of
the Institute. Human plasma was separated from the blood in EDTA-
anticoagulated tubes (Seditainer 1.8 vacutainer tubes, BD Inc., USA),
using ﬁve tubes for each Donor, and then centrifuged. The plasma from
all samples was pooled and a second step of centrifugation at 16,000
RPM for 10 min was applied to remove residual cells and cell debris.
The total protein content was measured in the pooled sample as 65g/L.
The within-subject and between-subject biological variation in total
protein content is 2.75 and 4.7, respectively, based on Westgard
database [27]. A plasma pool was used to get identical protein content
in all experiments. After freeze drying the product in a Flexi-Dry μP
lyophilizer (FTS Systems) using liquid nitrogen, it was stored at –18 °C
in small aliquots and separately thawed at room temperature for
individual experiments. For protein corona formation in HP, the
thawed aliquots were dissolved in UP water to make up the original
100% concentration and Tris buﬀered saline solution (pH~7.4 and
I~154 mM, Sigma-Aldrich) was used to dilute it to 1–80 v/v % for the
experiments. The experiments with the bare and core-shell MNPs were
performed in three replicates using separate plasma aliquots. Freeze
dried rather than fresh plasma was adequate for the series of our room
temperature experiments, as fresh plasma can only be stored for a
maximum of three days while refrigerated.
The evolution of the average particle size of the PE@MNPs (i.e.,
magnetite nanoparticles with polyelectrolyte (PE) shells from CA and
PAM) in the course of the protein corona formation was studied at 25
± 0.1 °C both as a function of HP concentration and time (i.e.,
measured at 3 min and 20 h after MNP incubation in plasma). For
particle size determination a Nano ZS (Malvern) dynamic light
scattering apparatus was used applying a 4 mW He−Ne laser source
(λ=633 nm) and operating in backscattering mode (at an angle of
173°). The pH and ionic strength was ﬁxed at pH~7.4 and I~150 mM
by the Tris buﬀered saline medium of HP solutions. The concentration
of PE@MNPs was 0.1 g/l optimized in preliminary experiments. The
aggregation state of the nanoparticles in the aqueous dispersions was
characterized by the Z-average hydrodynamic diameter (Zave) values.
We used the second- or third-order cumulant ﬁt of the autocorrelation
functions, depending on the degree of polydispersity. The variation of
Zave values was less than 5% for primary particles but the error
deﬁnition becomes irrelevant for large polydisperse aggregates.
The changes in the zeta potential due to protein corona formation
were determined in electrophoretic mobility measurements at 25 ±
0.1 °C by using a Nano ZS (Malvern) apparatus with disposable zeta
cells (DTS 1061). The experiments were performed at 20 h after MNP
incubation in plasma. The zeta potentials were calculated with the help
of the Smoluchowski equation. The accuracy of the measurements is ±
5 mV and the zeta-standard of Malvern (−55 ± 5 mV) was used for
calibration. The dispersions were diluted to achieve an optimal
intensity of ∼105 counts per second and an ionic strength value of
~10 mM. Prior to the measurements, the samples were homogenized in
an ultrasonic bath for 10 s, after which 2 min relaxation was allowed.
3. Results and discussion
Fig. 1 shows the C 1 s spectra of the core-shell MNPs and the
identiﬁcation of peaks is seen in the ﬁgure caption. The XPS spectra
clearly show the absence or presence of all chemical states of carbon
characteristic of the coatings. Alcoholic groups (–C–OH) were found in
the case of CA, while carboxylic groups (–C(O)–O) were found both in
CA- and PAM-coated MNPs, which corresponds with the chemical
structure of the coatings. Earlier FTIR-ATR experiments [23,24]
revealed that both CA and PAM are bound to the MNPs via formation
of inner-sphere Fe-carboxylate surface complexes the probable
schemes of which are demonstrated in Fig. 1.
We chose room temperature for testing the eﬀect of protein corona
formation on hydrodynamic size, zeta potential and colloidal stability
of the MNPs in human plasma. This is a frequent choice in literature
[28,29] and, while inaccurate to mimic in vivo conditions [9], it is
useful for comparing the in vitro behavior of diﬀerent nanoparticles.
For example, Mahmoudi et al. [30] found only a small deviation (~ ±
1 nm) between the hydrodynamic diameters of negatively charged
polymer coated FePt nanoparticles (rH~5 nm) incubated in human
serum albumin solutions in a 5 orders of magnitude concentration
range when measured at temperatures of 13, 23 and 43 °C.
The hydrodynamic diameter of all MNPs (Fig. 2) increased at low
plasma concentrations. The size increase is in the range of an order of
magnitude for the naked and CA-coated MNPs, which is likely due to
particle aggregation. PAM-coated particles were somewhat aggregated,
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but the size only doubled. With increasing HP concentration, the
aggregates prevalent at lower HP concentrations cannot form because
of the protecting eﬀect of further HP protein adsorption and corona
formation. Naked MNPs, however, remained aggregated in plasma –
the smallest observed hydrodynamic size at the highest HP concentra-
tions was ~400 nm. The size of the aggregates of the colloidally
unstable dispersions of naked and CA-coated MNPs (at HP concentra-
tions below 60 v/v % and between 1% and 10%, respectively) increased
signiﬁcantly with time (Fig. 2.b) revealing the absence of a full protein
corona. The aggregation state of the dispersions was visualized in
sedimentation experiments as demonstrated in Fig. 2.c. Visible sedi-
mentation in the test tubes reveals the presence of aggregates. In the
Fig. 1. C 1 s spectra of the core-shell MNPs and the schemes of Fe–O–C(O)–R binding between MNP iron sites and organic carboxylates. Peak positions for CA and PAM coated MNPs:
C-C, CH 284.91 and 285.27 eV; O–C=O 289.05 and 288.9 eV, respectively, and C-OH 285.75 eV for CA@MNP.
a b
3 min
20 h
c MNP CA@MNP PAM@MNP
Fig. 2. Changes in the hydrodynamic diameter of naked MNP (black) and polyelectrolyte-coated MNPs CA@MNP, blue, and PAM@MNP, red in function of the concentration of HP
measured 3 min and 20 h after dispersing them in HP solutions: panel (b) is the magniﬁcation of the plot in panel (a) in the low HP concentration range. In pictures (c) dispersions of
MNP, CA@MNP and PAM@MNP in HP solutions of 0–80% concentration can be seen as taken at 3 min and 20 h after dispersion preparation.
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absence of plasma proteins, naked MNP is fully destabilized in Tris
buﬀered saline (pH=7.4 and I=154 mM), while CA and PAM coating
improved the stability. In cases when there is no visible sedimentation,
both single particles and particle clusters with loose structure can be
evenly distributed in the medium, which is the case at higher plasma
concentrations for CA@MNP and at practically all plasma concentra-
tions for PAM@MNP. Thus, we can hypothesize that abrupt changes in
the hydrodynamic diameter of CA@MNP and PAM@MNP with plasma
concentration are more likely due to nanoparticle aggregation/cluster-
ing, while the gradual and moderate increase can more likely be caused
by the gradual increase in the thickness of the protein corona. Yallapu
et al. [31] found somewhat diﬀerent behavior of polyethylene glycol
coated MNPs in human serum. Their particles in principle were
uncharged and the serum lacks clothing factors, which can explain
the absence of MNP aggregation in their experiments at low serum
concentrations (i.e., no abrupt size increase was observed). However,
they also observed the gradual increase in the hydrodynamic diameter
from ~100 to 150–200 nm with increasing serum concentration,
similar to our ﬁndings. Gradual increase in the nanoparticle size with
plasma concentration was found by Monopoli et al. [32] for sulfonated
polystyrene and silica nanoparticles. Vogt et al. [33] found a three-fold
increase in the hydrodynamic diameter of silica-coated MNPs incu-
bated in whole plasma, while the DLS size of dextrane-coated MNPs
increased approximately by 30–40%. The general absence of observa-
tion of NP aggregation in literature can be due to the fact that the
smallest plasma concentrations are above 5–10%, while we found
strong aggregation at 1% and 2.53%. However, the comparison
between literature data is not fully straightforward because, in general,
the conditions of DLS measurements vary widely [34].
Notable changes in the hydrodynamic size were observed only
under the conditions of probable aggregation, i.e., the average size of
the aggregates increased with time. In contrast, the hydrodynamic size
of PAM@MNPs in the whole HP concentration range and that of MNP
and CA@MNP in HP of concentration higher than ~10 v/v % did not
change practically with time showing the likely absence of aggregation.
The zeta potential changes in the course of protein corona forma-
tion (Fig. 3) showed a quite unusual picture. The decrease in originally
negative values of zeta potential due to protein corona formation is
fully consistent with literature and similar to that in many diﬀerent
studies [32]. On ﬁrst encounter of HP proteins, naked and polyelec-
trolyte-coated MNPs (the original zeta potential of which is ~+15 and
~–35 mV, respectively) obtained negative potential values of similar
magnitude (between ~–10 and ~–25 mV). Overcharging of the posi-
tively charged naked MNPs is in line with expectations, but the ~–
15 mV charge compensation (from +15 to 0 mV) and the ~–10 mV
overcharging (from 0 to −10 mV) would suggest the presence of an
excess negative charge of adsorbed proteins in the order of −25 mV,
which is ﬁve times of that of HP in solution (−5 mV). The ~10 mV
decrease in the absolute values of negative zeta potentials of the core-
shell MNPs to −25 mV is also against intuition. Further detailed
electrokinetic potential studies are necessary to ﬁnd the explanation
of our ﬁrst results, but it is clear that other speciﬁc interactions
dominate over the general eﬀects expected from physico-chemical
charge-potential correlations.
After reaching an equilibrium state of the zeta potential of protein
corona-coated MNPs at 10% concentration of HP medium, the negative
values of zeta potentials begin to increase gradually with increasing
plasma concentration. The latter observation is readily explained by the
gradual adsorption of HP proteins introducing additional excess
negative charges to the corona. Zeta potential measurements of protein
corona coated nanoparticles in function of the protein source concen-
tration were not found in our literature search range.
4. Conclusions
We studied the changes in hydrodynamic diameter and zeta
potential of MNPs in the course of protein corona formation both as
a function of human plasma concentration and time. The main ﬁndings
follow from our studies as listed below.
(i) Naked and CA-coated MNPs cannot be properly stabilized in
human plasma due to protein corona formation. Allowing suﬃ-
cient time for corona formation also does not lead to the
formation of colloidally stable dispersions.
(ii) PAM coating stabilizes the MNPs eﬃciently at higher HP con-
centrations and the stability is practically independent of the time
allowed for corona formation.
(iii) Zeta potential measurements reveal the complex nature of the
protein corona expressed as the complete absence of correlation
between its nominal charge and zeta potential as it should be
expected on the basis of general physical chemistry.
(iv) Additionally, there is no correlation as well between the zeta
potentials of the particles (with or without fully developed protein
corona at higher or lower HP concentrations, respectively) and
their observed colloidal stability.
The latter two ﬁndings clearly show that further studies should be
designed to clarify the mechanism of charge compensation in the
course of protein corona formation around magnetite nanoparticles in
human plasma.
Most importantly, we found that some MNP coatings, such as citric
acid shell, for example, cannot protect the nanoparticles against
aggregation if administered intravenously. Aggregated at the locus of
IV injection, CA@MNPs should be able to redisperse in the blood
stream in order to avoid blocking small arteries. Also further studies
should clarify whether their redispersion in vivo is possible.
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